These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective clinical phase II study of two new indwelling voice prostheses (Provox Vega 22.5 and 20 Fr) and a novel anterograde insertion device (Provox Smart Inserter). Hilgers FJ, Ackerstaff AH, Jacobi I, Balm AJ, Tan IB, van den Brekel MW. Laryngoscope; 2010 Jun; 120(6):1135-43. PubMed ID: 20513030 [Abstract] [Full Text] [Related]
4. In vitro and in vivo comparison of the low-resistance Groningen and the Provox tracheosophageal voice prostheses. Chung RP, Patel P, Ter Keurs M, Van Lith Bijl JT, Mahieu HF. Rev Laryngol Otol Rhinol (Bord); 1998 Jun; 119(5):301-6. PubMed ID: 10089797 [Abstract] [Full Text] [Related]
10. Compliance, quality of life and quantitative voice quality aspects of hands-free speech. Op de Coul BM, Ackerstaff AH, van As-Brooks CJ, van den Hoogen FJ, Meeuwis CA, Manni JJ, Hilgers FJ. Acta Otolaryngol; 2005 Jun; 125(6):629-37. PubMed ID: 16076712 [Abstract] [Full Text] [Related]
11. A comparison of survival lifetime of the Provox and the Provox2 voice prosthesis. Lequeux T, Badreldin A, Saussez S, Thill MP, Oujjan L, Chantrain G. J Laryngol Otol; 2003 Nov; 117(11):875-8. PubMed ID: 14670148 [Abstract] [Full Text] [Related]
18. Voice rehabilitation with Provox2 voice prosthesis following total laryngectomy for laryngeal and hypopharyngeal carcinoma. Terada T, Saeki N, Toh K, Uwa N, Sagawa K, Takayasu S, Sakagami M. Auris Nasus Larynx; 2007 Mar; 34(1):65-71. PubMed ID: 17137738 [Abstract] [Full Text] [Related]